用化疗 (Imatinib Mesylate) 治疗恶性直肠GIST:一个病例报告和综合性审查
Amrit Bhusal1, Suraj Kc2, Tek Nath Yogi3
1Department of Radio-diagnostics and Imaging, BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Sunsari, Nepal.
Radiology case reports
|January 31, 2024
概括
胃肠道 stromal 瘤 (GIST) 是一种罕见的直肠瘤. 这种病例突出显示了直肠GIST转移到肝脏和肺部,并通过Imatinib Mesylate成功治疗.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 胃肠道 stromal 瘤 (GIST) 是消化道中最常见的介质细胞瘤.
- 胃肠瘤起源于Cajal的间歇细胞,约占所有胃肠道瘤的1%.
- 直肠GIST非常罕见,约占所有GIST的5%和直肠瘤的0.1%.
更多相关视频
05:16Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
5.9K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.7K
